Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone Acetate vs Aromatase Inhibitor in ER+ Breast Cancer
NCT01814865Phase 2Withdrawn
- Sponsor
- BC Cancer
- Start
- May 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Abiraterone Acetate Tablets (I) in breast cancer, sponsored by BC Cancer. Planned start May 2013; status: withdrawn.
02
Drugs
Abiraterone Acetate Tablets (I)
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01814865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01814865.